The mutations in FGFR2-associated craniosynostoses are clustered in five structural elements of immunoglobulin-like domain III of the receptor

Human Genetics

Volumn 102, Issue 2, 1998, Pages 145-150

  Steinberger, Daniela ^a   Vriend, Gert ^b   Mulliken, John B ^c   Müller, Ulrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN;

ACROCEPHALOSYNDACTYLY; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; EXON; GENE CLUSTER; GENE MAPPING; HUMAN; HUMAN CELL; LIGAND BINDING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN;

CRANIOFACIAL DYSOSTOSIS; CRANIOSYNOSTOSES; DNA MUTATIONAL ANALYSIS; HUMANS; IMMUNOGLOBULINS; MODELS, MOLECULAR; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; SYNDROME;

EID: 0031896814     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050668     Document Type: Article

References (37)

1. Bateman A, Chothia C (1995) Outline structures for the extracellular domains of the fibroblast growth factor receptors. Nat Struct Biol 2:1068-1074
2. Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M (1996) Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 14:174-176
3. Bork P, Holm L, Sander C (1994) The immunoglobulin fold structural classification, sequence patterns and common core. J Mol Biol 242:309-320
4. Chinea G, Padron G, Hooft RW, Sander C, Vriend G (1995) The use of position-specific rotamers in model building by homology. Proteins 23:415-421
5. Del Gatto F, Breathnach R (1995) Crouzon syndrome synonymous mutation activates a 5′ splice site within the IIIc exon of the FGFR2 gene. Genomics 27:558-559
6. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J (1990) Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9: 2685-2692
7. Furey Jr W, Wang BC, Yoo CS, Sax M (1983) Structure of a novel Bence-Jones protein (Rhe) fragment at 1.6 Angstroms resolution. J Mol Biol 167:661-692
8. Givol D, Yayon A (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6:3362-3369
9. Gorry MC, Preston RA, White GJ, Zhang Y, Singhal VK, Losken HW, Parker MG, Nwokoro NA, Post JC, Ehrlich GD (1995) Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet 4:1387-1390
10. Houssiant E, Blanquet PR, Champion-Arnaud P, Gesnel MC, Torriglia A, Courtois Y, Breathnach R (1990) Related fibroblast growth factor receptor genes exist in the human genome. Proc Natl Acad Sci USA 87:8180-8184
11. Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao J, Charnas LR, Jackson CE, Jaye M (1994) Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor-2. Nat Genet 8:275-279
12. Johnson DE, Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60: 1-41
13. Johnson DE, Lu J, Chen H, Werner S, Williams LT (1991) The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11:4627-4634
14. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54
15. Lajeunie E, Ma HW, Bonaventure J, Munnich A, LeMerrer M, Renier D (1995) FGFR2 mutations in Pfeiffer syndrome. Nat Genet 9:108
16. Ma HW, Lajeunie E, LeMerrer ML, Parseval N de, Serville F, Weissenbach J, Munnich A, Renier D (1995) No evidence of genetic heterogeneity in Crouzon craniofacial dysostosis. Hum Genet 96:731-735
17. Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA, Abrams LJ, Graham JM, Feingold M, Moeschler JB, Rawnsley E, Scott AF, Jabs EW (1996) FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: Evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 58:491-498
18. Neilson KM, Friesel RE (1995) Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J Biol Chem 270:26037-26040
19. Neilson KM, Friesel RE (1996) Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J Biol Chem 271:25049-25057
20. Oldridge M, Wilkie AOM, Slaney SF, Poole MD, Pulleyn LJ, Rutland P, Hockley AD, Wake MJC, Goldin JH, Winter RM, Reardon W, Malcolm S (1995) Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum Mol Genet 4:1077-1082
21. Oldridge M, Lunt PW, Zackai EH, McDonald-McGinn DM, Muenke M, Moloney DM, Twigg SRF, Heath JK, Howard TD, Hoganson G, Gagnon DM, Jabs EW, Wilkie AOM (1997) Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. Hum Mol Genet 6:137-143
22. Park WJ, Meyers, GA, Li X, Theda C, Day D, Orlow SJ, Jones MC, Jabs EW (1995a) Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 4:1229-1233
23. Park WJ, Theda C, Maestri NE, Meyers GA, Fryburg JS, Dufresne C, Cohen Jr MM, Jabs EW (1995b) Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet 57:321-328
24. Pulleyn LJ, Reardon W, Wilkes D, Rutland P, Jones BM, Hayward R, Hall CM, Brueton L, Chun N, Lammer E, Malcolm S, Winter RM (1996) Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locus. Eur J Hum Genet 4:283-291
25. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 8:98-103
26. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF, Poole MD, Wilkie AOM (1995) Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 9:173-176
27. Schell U, Hehr A, Feldmann GJ, Robin NH, Zackai EH, DieSmulders C de, Viskochil DH, Stewart JM, Wolff G, Ohashi H, Price RA, Cohen MM, Muenke M (1995) Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet 4:323-328
28. Schwartz M, Kreiborg S, Skovby F (1996) First-trimester prenatal diagnosis of Crouzon syndrome. Prenat Diagn 16:155-158
29. Slaney SF, Oldridge M, Hurst JA, Morriss-Kay GM, Hall CM, Poole MD, Wilkie AOM (1996) Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet 58:923-932
30. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79:1015-1024
31. Steinberger D, Mulliken JB, Müller U (1995) Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome. Hum Genet 96:113-115
32. Steinberger D, Mulliken JB, Müller U (1996a) Crouzon syndrome: previously unrecognized deletion, duplication and point mutation within FGFR2 gene. Hum Mutat 8:386-390
33. Steinberger D, Reinhartz T, Unsöld R, Müller U (1996b) FGFR2 mutation in clinically nonclassifiable autosomal dominant craniosynostosis with pronounced phenotypic variation. Am J Med Genet 66:81-86
34. Steinberger D, Collmann H, Schmalenberger B, Müller U (1997) A novel mutation (a886→g) in exon 5 of FGFR2 in members of a family with Crouzon phenotype and plagiocephaly. J Med Genet 34:420-422
35. Vriend G (1990) WHAT IF: a molecular modeling and drug design program. J Mol Graph 8:52-56
36. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9:165-172
37. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991) Cell surface heparin-like molecules are required for binding of bFGF to its high affinity receptor. Cell 64:841-848